Prognostic significance of IL‐18 in acute coronary syndrome patients
Key Points:
- Elevated IL-18 levels are associated with worse clinical outcomes, including increased risk of major adverse cardiovascular events in ACS patients.
- The study highlights the role of IL-18 in inflammation-driven atherosclerosis and its potential as a prognostic biomarker.
- Findings emphasize the need for further research on IL-18-targeted therapies to improve risk assessment and management in ACS.
Description
This study explores the prognostic significance of interleukin-18 (IL-18) in patients with acute coronary syndrome (ACS). By analyzing existing research, it evaluates IL-18 as a biomarker for predicting adverse cardiovascular events and patient outcomes.
Be the first to review “Prognostic significance of IL‐18 in acute coronary syndrome patients”
Reviews
There are no reviews yet.